| Identification | Back Directory | [Name]
Benzamide, N-[3-[7-[[6-[4-[3-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]propyl]-1-piperazinyl]-3-pyridinyl]amino]-1,4-dihydro-1-methyl-2-oxopyrimido[4,5-d]pyrimidin-3(2H)-yl]-4-methylphenyl]-3-(trifluoromethyl)- | [CAS]
2769753-51-5 | [Synonyms]
Benzamide, N-[3-[7-[[6-[4-[3-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]propyl]-1-piperazinyl]-3-pyridinyl]amino]-1,4-dihydro-1-methyl-2-oxopyrimido[4,5-d]pyrimidin-3(2H)-yl]-4-methylphenyl]-3-(trifluoromethyl)- | [Molecular Formula]
C47H44F3N11O7 | [MOL File]
2769753-51-5.mol | [Molecular Weight]
931.92 |
| Hazard Information | Back Directory | [Uses]
DB0662 is a compound for kinase-targeted protein degradation and can be used in studies of diseases mediated by abnormal kinase activity, as well as for the identification of degradable kinases and optimal kinases[1]. | [References]
[1] Nathanael S. Gray, et al. Compounds for targeted protein degradation of kinases. WO2022093742. |
|
|